Report of Foreign Issuer (6-k)
June 30 2016 - 8:15AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
Report of Foreign Private Issuer Pursuant
to Rule 13a-16 or 15d-16
Under the Securities Exchange Act of
1934
For the Month of June 2016
Commission File No.: 001-33514
TRANSITION THERAPEUTICS INC.
101 College Street, Suite 220, Toronto,
Ontario, Canada M5G 1L7
(Address of Principal Executive Office)
Indicate by check mark whether the registrant files or will
file annual reports under cover of Form 20-F or Form 40-F. Form 20-F
ý
Form
40-F
¨
Indicate by check mark if the registrant is submitting the Form
6-K in paper as permitted by Regulation S-T Rule 101(b)(1): Yes
¨
No
ý
Indicate by check mark if the registrant is submitting the Form
6-K in paper as permitted by Regulation S-T Rule 101(b)(7): Yes
¨
No
ý
The information furnished herewith is incorporated by reference
into the following Registration Statements:
Registration Statement on
Form S-8 No. 333-157279
Registration Statement on Form F-3 No. 333-189879
EXHIBITS
The following information is furnished to the SEC as part of
this report on Form 6-K:
Exhibit No.
|
Document
|
|
|
99.1
|
Press Release dated June 30, 2016: “OPKO Health to Acquire Transition Therapeutics.”
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act
of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
TRANSITION THERAPEUTICS INC.
|
|
|
|
Date: June 30, 2016
|
By:
|
/s/ Nicole Rusaw
|
|
Name:
|
Nicole Rusaw
|
|
Title:
|
Chief Financial Officer
|
Transition Therapeutics - Ordinary Shares (NASDAQ:TTHI)
Historical Stock Chart
From Sep 2024 to Oct 2024
Transition Therapeutics - Ordinary Shares (NASDAQ:TTHI)
Historical Stock Chart
From Oct 2023 to Oct 2024